The document summarizes sales information for Medix and the pharmaceutical market in Mexico from 2003 to 2011. It shows that from 2003 to 2007, Medix's average annual sales increase was 0.2% ($26 million), while from March 2011 its average annual sales increase was 22% ($309 million). It also provides data on Medix's market share and sales of its obesity drug Obeclox from its launch in 2005 to 2010.